Confirmed efficacy and safety of dual therapy based in lamivudine plus a ritonavir-boosted protease inhibitor in the clinical setting

被引：0
|
作者：
Fontecha-Ortega, Maria [1 ]
Munoz-Mendoza, Vanessa [2 ]
Gomez, Cristina [3 ]
Sanchez-Conde, Matilde [3 ]
Angel Rodriguez, Miguel [3 ]
Jesus Vivancos, Maria [3 ]
Luis Casado, Jose [3 ]
机构：
[1] Hosp Getafe, Internal Med, Getafe, Spain
[2] Hosp Obispo Polanco, Internal Med, Teruel, Spain
[3] Hosp Ramon & Cajal, Infect Dis, Madrid, Spain
来源：
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY | 2016年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
P103
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Safety and efficacy of a double-boosted protease inhibitor combination, saquinavir and lopinavir/ritonavir, in pretreated children at 96 weeks
    Bunupuradah, Torsak
    van der Lugt, Jasper
    Kosalaraksa, Pope
    Engchanil, Chulapan
    Boonrak, Pitch
    Puthanakit, Thanyawee
    Mengthaisong, Tawan
    Mahanontharit, Apicha
    Lumbiganon, Pagakrong
    Tompkins, Emily
    Burger, David
    Ruxrungtham, Kiat
    Ananworanich, Jintanat
    ANTIVIRAL THERAPY, 2009, 14 (02) : 241 - 248
  • [42] Dual therapy with a boosted protease inhibitor plus lamivudine is an effective maintenance strategy in patients on second-line antiretroviral therapy in Africa: the ANRS 12286/MOBIDIP trial
    Ciaffi, Laura
    Koulla-Shiro, Sinata
    Sawadogo, Adrien
    Gueye, N. Fatou Ngom
    Le Moing, Vincent
    Eymard-Duvernay, Sabrina
    Izard, Suzanne
    Zoungrana, Jacques
    Mbouyap, Pretty
    Diallo, Mamadou
    Bado, Guillaume
    Kane, Koumba Toure
    Aghokeng, Avelin
    Peeters, Martine
    Reynes, Jacques
    Delaporte, Eric
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2016, 19
  • [43] Neurocognitive safety after 96 weeks on dual therapy with atazanavir/ritonavir plus lamivudine: results of the neurocognitive substudy of the SALT randomized clinical trial
    Perez-Valero, Ignacio
    Pasquau, Juan
    Rubio, Rafael
    Rivero, Antonio
    Santos, Jose
    Sanz, Jesus
    Marino, Ana
    Crespo, Manel
    Hernandez-Quero, Jose
    Antonio Iribarren, Jose
    Gutierrez, Felix
    Terron, Alberto
    Esteban, Herminia
    Antonio Perez-Molina, Jose
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2018, 73 (09) : 2444 - 2451
  • [44] Switching from a ritonavir-boosted protease inhibitor to a dolutegravir-based regimen for maintenance of HIV viral suppression in patients with high cardiovascular risk
    Gatell, Jose M.
    Assoumou, Lambert
    Moyle, Graeme
    Waters, Laura
    Johnson, Margaret
    Domingo, Pere
    Fox, Julie
    Martinez, Esteban
    Stellbrink, Hans-Juergen
    Guaraldi, Giovanni
    Masia, Mar
    Gompels, Mark
    De Wit, Stephane
    Florence, Eric
    Esser, Stefan
    Raffi, Francois
    Pozniak, Anton L.
    AIDS, 2017, 31 (18) : 2503 - 2514
  • [45] Dual therapy with dolutegravir plus boosted protease inhibitor as maintenance or salvage therapy in highly experienced people living with HIV
    Lee, Yu-Lin
    Lin, Kuan-Yin
    Cheng, Shu-Hsing
    Lu, Po-Liang
    Wang, Ning-Chi
    Ho, Mao-Wang
    Yang, Chia-Jui
    Liou, Bo-Huang
    Tang, Hung-Jen
    Huang, Shie-Shian
    Huang, Sung-Hsi
    Chen, Tun-Chieh
    Lin, Chi-Ying
    Lin, Shih-Ping
    Lee, Yuan-Ti
    Hung, Chien-Ching
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2021, 58 (03)
  • [46] Examining the efficacy in clinical practice of the dual antiretroviral therapy regimen of boosted protease inhibitors with maraviroc
    Katiyar, A.
    Burns, F.
    Swaden, L.
    Youle, M.
    Barber, T.
    HIV MEDICINE, 2020, 21 : 16 - 16
  • [47] Examining the efficacy in clinical practice of the dual antiretroviral therapy regimen of boosted protease inhibitors with maraviroc
    Katiyar, A.
    Burns, F.
    Swaden, L.
    Youle, M.
    Barber, T. J.
    HIV MEDICINE, 2019, 20 : 63 - 63
  • [48] Switching to boosted protease inhibitor plus a second antiretroviral drug (dual therapy) for treatment simplification: a multicenter analysis
    Zaccarelli, Mauro
    Fabbiani, Massimiliano
    Pinnetti, Carmela
    Borghi, Vanni
    Giannetti, Alberto
    Sterrantino, Gaetana
    Lorenzini, Patrizia
    Latini, Alessandra
    Loiacono, Laura
    Colagli, Manuela
    Ammassari, Adriana
    D'Ettorre, Gabriella
    Plazzi, Maddalena
    Di Giambenedetto, Simona
    Antinori, Andrea
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2014, 17 : 188 - 189
  • [49] Efficacy and Safety of Darunavir/Ritonavir Plus Etravirine Dual Regimen in Antiretroviral Therapy-Experienced Patients: A Multicenter Clinical Experience
    Gazzola, Lidia
    Cicconi, Paola
    Ripamonti, Diego
    Di Filippo, Elisa
    Gustinetti, Giulia
    Di Biagio, Antonio
    Marchetti, Giulia
    Bini, Teresa
    Monforte, Antonella d'Arminio
    HIV CLINICAL TRIALS, 2014, 15 (04): : 140 - 150
  • [50] Protease inhibitor-based regimens for HIV therapy - Safety and efficacy
    Walmsley, Sharon
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2007, 45 : S5 - S13
12345